Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants

被引：0
|
作者：
Valerie Pestinger
Matthew Smith
Toju Sillo
John M. Findlay
Jean-Francois Laes
Gerald Martin
Gary Middleton
Phillipe Taniere
Andrew D. Beggs
机构：
[1] University of Birmingham,Surgical Research Laboratory, Institute of Cancer and Genomic Sciences
[2] Queen Elizabeth Hospital Birmingham,Institute of Immunology and Immunotherapy
[3] Northern Devon Healthcare NHS Trust,undefined
[4] OncoDNA,undefined
[5] PierianDx,undefined
[6] University of Birmingham,undefined
来源：
Molecular Diagnosis & Therapy | 2020年 / 24卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：339 / 349
页数：10
相关论文
共 31 条
  • [1] Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants
    Pestinger, Valerie
    Smith, Matthew
    Sillo, Toju
    Findlay, John M.
    Laes, Jean-Francois
    Martin, Gerald
    Middleton, Gary
    Taniere, Phillipe
    Beggs, Andrew D.
    MOLECULAR DIAGNOSIS & THERAPY, 2020, 24 (03) : 339 - 349
  • [2] Correction to: Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants
    Valerie Pestinger
    Matthew Smith
    Toju Sillo
    John M. Findlay
    Jean‑Francois Laes
    Gerald Martin
    Gary Middleton
    Phillipe Taniere
    Andrew D. Beggs
    Molecular Diagnosis & Therapy, 2020, 24 : 505 - 505
  • [3] Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants (vol 24, pg 339, 2020)
    Pestinger, Valerie
    Smith, Matthew
    Sillo, Toju
    Findlay, John M.
    Laes, Jean-Francois
    Martin, Gerald
    Middleton, Gary
    Taniere, Phillipe
    Beggs, Andrew D.
    MOLECULAR DIAGNOSIS & THERAPY, 2020, 24 (04) : 505 - 505
  • [4] Performance of next-generation sequencing for detection of clinically actionable genetic variants in cancer.
    Hussaini, Mohammed Omar
    Hagemann, Ian S.
    Cox, Teresa Mary
    Lockwood, Christina
    Seibert, Karen
    Kulkarni, Shashikant
    Pfeifer, John
    Duncavage, Eric James
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [5] Pan-cancer Analysis of Tumor Mutational Burden and Homologous Recombination DNA Damage Repair Using Targeted Next-Generation Sequencing
    Wang, Hai-Yun
    Deng, Ling
    Li, Ying-Qing
    Zhang, Xiao
    Long, Ya-Kang
    Zhang, Xu
    Feng, Yan-Fen
    He, Yuan
    Tang, Tao
    Yang, Xin-Hua
    Wang, Fang
    CANCER RESEARCH AND TREATMENT, 2021, 53 (04): : 973 - 982
  • [6] Tumor Mutation Burden Computation in Two Pan-Cancer Precision Medicine Next-Generation Sequencing Panels
    Shu, Yongqian
    Wu, Xiaohong
    Shen, Jia
    Luo, Dongdong
    Li, Xiang
    Wang, Hailong
    Tang, Yuanhua Tom
    JOURNAL OF COMPUTATIONAL BIOLOGY, 2020, 27 (10) : 1553 - 1560
  • [7] Utilization of a Next-Generation Sequencing Cancer Mutation Panel to Detect High-Frequency and Clinically Actionable Mutations in Colorectal Cancer
    Robinson, B. S.
    Martinez, A. P.
    Schnieder, T.
    Hill, C.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (06): : 841 - 841
  • [8] Adaptation and Validation of a Pan-cancer Somatic Next Generation Sequencing Assay for Detection of Germline Hereditary Cancer Predisposition Variants
    Manning, D. K.
    Garcia, E. P.
    Davineni, P. K.
    Bialic, L.
    Ducar, M. D.
    Shivdasani, P.
    Church, A. J.
    Simmons, D. P.
    Li, Y. Y.
    Jacobs, R. K.
    Baltay, M.
    Sotelo, J.
    MacConaill, L. E.
    Lindeman, N. I.
    Nowak, J. A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (06): : 909 - 909
  • [9] Validation and Clinical Implementation of a Pan-Cancer Circulating Tumor DNA-based Next-Generation Sequencing Assay
    Zheng, G.
    Schneider, A.
    Campion, M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2023, 25 (06): : S46 - S47
  • [10] Original Research Tumour mutational burden, microsatellite instability, and actionable alterations in metastatic colorectal cancer: Next-generation sequencing results of TRIBE2 study
    Antoniotti, Carlotta
    Korn, W. Michael
    Marmorino, Federica
    Rossini, Daniele
    Lonardi, Sara
    Masi, Gianluca
    Randon, Giovanni
    Conca, Veronica
    Boccaccino, Alessandra
    Tomasello, Gianluca
    Passardi, Alessandro
    Swensen, Jeff
    Ugolini, Clara
    Oberley, Matthew
    Tamburini, Emiliano
    Casagrande, Mariaelena
    Domenyuk, Valeriy
    Fontanini, Gabriella
    Giordano, Mirella
    Abraham, Jim
    Spetzler, David
    Falcone, Alfredo
    Lenz, Heinz-Josef
    Cremolini, Chiara
    EUROPEAN JOURNAL OF CANCER, 2021, 155 : 73 - 84
1234